Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

Hua Medicine Stages $110 Million Hong Kong IPO at $1.1 Billion Valuation
EpimAb Files US/China INDs for Bispecific Cancer Antibody
111, a Shanghai Online-Offline Pharmacy, Raises $100 Million in US IPO
Xynomic Pharma to List on Nasdaq via Reverse-Merger at $450 Million Valuation
Vivo Capital Closes Latest US-China PE Fund at $635 Million
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Other Events



November 7–9, 2018

ChinaBio members can get a 20% discount with the promotion code"chinabio18"